286 related articles for article (PubMed ID: 33101202)
1. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women.
Ramanjaneya M; Bensila M; Bettahi I; Jerobin J; Samra TA; Aye MM; Alkasem M; Siveen KS; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB
Front Endocrinol (Lausanne); 2020; 11():568500. PubMed ID: 33101202
[No Abstract] [Full Text] [Related]
2. Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects.
Ramanjaneya M; Jerobin J; Bettahi I; Bensila M; Aye M; Siveen KS; Sathyapalan T; Skarulis M; Abou-Samra AB; Atkin SL
Clin Endocrinol (Oxf); 2019 Aug; 91(2):278-287. PubMed ID: 31066084
[TBL] [Abstract][Full Text] [Related]
3. Regulation of circulating CTRP-2/CTRP-9 and GDF-8/GDF-15 by intralipids and insulin in healthy control and polycystic ovary syndrome women following chronic exercise training.
Jerobin J; Ramanjaneya M; Bettahi I; Parammal R; Siveen KS; Alkasem M; Aye M; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB
Lipids Health Dis; 2021 Apr; 20(1):34. PubMed ID: 33874963
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
Wang D; Zhu W; Li J; An C; Wang Z
PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
[TBL] [Abstract][Full Text] [Related]
5. Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome.
Liu S; Hu W; He Y; Li L; Liu H; Gao L; Yang G; Liao X
BMC Endocr Disord; 2020 May; 20(1):67. PubMed ID: 32429902
[TBL] [Abstract][Full Text] [Related]
6. Serum Fetuin-A levels in women with polycystic ovary syndrome.
Gulhan I; Bozkaya G; Oztekin D; Uyar I; Kebapcilar AG; Pamuk B
Arch Gynecol Obstet; 2012 Dec; 286(6):1473-6. PubMed ID: 22865037
[TBL] [Abstract][Full Text] [Related]
7. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome.
Abali R; Celik C; Tasdemir N; Guzel S; Alpsoy S; Yuksel A; Celik E
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):45-9. PubMed ID: 23433744
[TBL] [Abstract][Full Text] [Related]
8. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
[TBL] [Abstract][Full Text] [Related]
9. Elevated Circulating Fetuin-B Levels Are Associated with Insulin Resistance and Reduced by GLP-1RA in Newly Diagnosed PCOS Women.
Mokou M; Yang S; Zhan B; Geng S; Li K; Yang M; Yang G; Deng W; Liu H; Liu D; Zhu Z; Li L
Mediators Inflamm; 2020; 2020():2483435. PubMed ID: 33061822
[TBL] [Abstract][Full Text] [Related]
10. Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome.
Bednarska S; Fryczak J; Siejka A
Cytokine; 2020 Oct; 134():155188. PubMed ID: 32673996
[TBL] [Abstract][Full Text] [Related]
11. Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome.
Aye MM; Kilpatrick ES; Aburima A; Wraith KS; Magwenzi S; Spurgeon B; Rigby AS; Sandeman D; Naseem KM; Atkin SL
J Am Heart Assoc; 2014 Feb; 3(1):e000706. PubMed ID: 24584741
[TBL] [Abstract][Full Text] [Related]
12. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.
Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887
[TBL] [Abstract][Full Text] [Related]
13. Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men.
Willis SA; Sargeant JA; Yates T; Takamura T; Takayama H; Gupta V; Brittain E; Crawford J; Parry SA; Thackray AE; Varela-Mato V; Stensel DJ; Woods RM; Hulston CJ; Aithal GP; King JA
J Nutr; 2020 May; 150(5):1076-1085. PubMed ID: 31919514
[TBL] [Abstract][Full Text] [Related]
14. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
15. FGF19 subfamily members: FGF19 and FGF21.
Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
[TBL] [Abstract][Full Text] [Related]
16. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
Enli Y; Fenkci SM; Fenkci V; Oztekin O
Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
[TBL] [Abstract][Full Text] [Related]
17. Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome.
Kahraman S; Altinova AE; Yalcin MM; Gulbahar O; Arslan B; Akturk M; Cakir N; Toruner FB
J Endocrinol Invest; 2018 Sep; 41(9):1069-1074. PubMed ID: 29363048
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
19. Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.
Kondo Y; Komaba H; Fukagawa M
Expert Rev Mol Diagn; 2020 Jul; 20(7):715-724. PubMed ID: 32513031
[TBL] [Abstract][Full Text] [Related]
20. Fetuin-A levels in lean and obese women with polycystic ovary syndrome.
Kozakowski J; Jeske W; Zgliczyński W
Endokrynol Pol; 2014; 65(5):371-6. PubMed ID: 25301487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
